Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T02:41:18.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the completed study of pembrolizumab plus radium-223 for metastatic castration-resistant prostate cancer is displayed, including its study design, eligibility criteria, outcomes, and investigator information.
    Difference
    57%
    Check dated 2026-11-11T01:45:17.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:07:06.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A sitewide NIH notice about terminology changes appears above the page, and the site revision updates from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:09:58.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:27:06.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Access to the study record returns a 403 Forbidden page instead of the study details, preventing viewing the trial information. The page displays a 403 message with a Home button, indicating restricted access to the content.
    Difference
    20%
    Check dated 2026-09-23T00:18:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.